Overview

Camber Specialty will support the increasing demand for these products by providing hospitals, clinics, government facilities, and other institutional partners more high-quality generic choices. The company’s parent company, Hetero Labs, has made a commitment to launching a deep pipeline of Specialty products with dosage forms that include injectable, ophthalmic, infusion, and specialty oral solids. Hetero is a global supplier of critical care products including those used as rare disease therapies. Oncology care remains at the heart of the organization’s goals for future products. The company has a deep pipeline of products for the treatment cancer, based in the therapeutic Oncology class of drugs. Our institutional partners will have the strength of Camber, a leading generic company, focusing its resources on bringing to market important generic injectable molecules.